DGAP-News: Burcon NutraScience Corp.: BURCON PROVIDES UPDATE ON CANOLA LICENSE&DEVELOPMENT AGREEMENT
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: BURCON PROVIDES UPDATE ON CANOLA LICENSE&DEVELOPMENT AGREEMENT
07.03.2011 / 07:11
---------------------------------------------------------------------
BURCON PROVIDES UPDATE ON CANOLA LICENSE&DEVELOPMENT AGREEMENT
Vancouver, British Columbia, March 4, 2011 - Burcon NutraScience
Corporation (TSX - BU) announced today that the company has amended the
license and development agreement between Burcon, Burcon NutraScience (MB)
Corp. and Archer Daniels Midland Company ('ADM') to provide an extended
development period for continued research aimed at expanding the commercial
value of Puratein(R) and Supertein(TM).
Burcon and ADM have agreed to an amendment of the license and development
agreement to effectively provide a one-year extension to March 1, 2012, to
facilitate continued research.
Burcon's main research objective during the one-year term of this amendment
is to further the commercialization potential of Burcon's canola protein
products Puratein and Supertein, particularly with respect to their unique
functional and nutritional characteristics. As such, Burcon will conduct
research aimed at refining its canola extraction and purification
technologies, develop new technologies as well as specialized canola
protein products. The amendment contemplates that Burcon may, at its sole
discretion and expense, engage a third party research organization to
conduct a joint research study, including human clinical feeding trials,
designed to investigate Supertein's potential as a functional food
ingredient. In particular, the research would seek to develop evidence of
Supertein's ability - given its high cysteine content - to mitigate certain
physiological effects associated with metabolic syndrome.
'Burcon has focused on commercializing our CLARISOY(R) technology for the
past few years and now we are able to devote more resources toward our
canola protein technologies,' commented Johann F. Tergesen, president and
COO of Burcon, adding, 'We remain excited about the potential for canola
protein to earn an important share of the protein ingredient industry as a
result of its unique inherent nutritional and functional characteristics.'
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We are developing
Puratein(R) and Supertein(TM) canola protein isolates with unique
functional and nutritional attributes, and CLARISOY(R), a revolutionary soy
protein which is 100% soluble and completely transparent in acidic
solutions. Our team of highly specialized scientists and engineers work
from our own research facility to develop and optimize environmentally
sound technologies. To-date, our patent portfolio consists of 151 issued
patents in various countries, including 25 issued U.S. patents, and in
excess of 250 additional pending patent applications, 65 of which are U.S.
patent applications.
###
ON BEHALF OF THE BOARD OF DIRECTORS
'Johann F. Tergesen'
Johann F. Tergesen
President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements that involve risks and
uncertainties. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words
'goal', 'intend', 'believes' and 'potential' and similar expressions,
generally identify forward-looking statements. These statements reflect our
current expectations. They are subject to a number of risks and
uncertainties. In light of the many risks and uncertainties surrounding the
development of a source of protein from canola meal, you should understand
that we cannot assure you that the forward looking statements contained in
this press release will be realized.
For more information, please contact:
Jade Cheng, Chief Financial Officer
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
jcheng(at)burcon.ca www.burcon.ca
End of Corporate News
---------------------------------------------------------------------
07.03.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
114554 07.03.2011
Bereitgestellt von Benutzer: EquityStory
Datum: 07.03.2011 - 07:11 Uhr
Sprache: Deutsch
News-ID 33389
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: BURCON PROVIDES UPDATE ON CANOLA LICENSE&DEVELOPMENT AGREEMENT"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).